A new test in development may be able to detect both COVID-19 and the flu at the same time. Continuing Coverage: Coronavirus in Wisconsin"It's a test that simultaneously looks for influenza and the ...
QIAGEN N.V. QGEN recently received Emergency Use Authorization (EUA) from the FDA for the NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Assay. Notably, the polymerase chain reaction (PCR) multiplex test will ...
A new blood test called the Tick-Borne Disease Serochip (TBD Serochip) promises to revolutionize the diagnosis of tick-borne disease by offering a single test to identify and distinguish between ...
(RTTNews) - Qiagen N.V. (QGEN) announced Monday that the U.S. Food and Drug Administration or FDA has granted Emergency Use Authorization for the NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Test. The ...
GERMANTOWN, Md. & HILDEN, Germany--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the European launch of the NeuMoDx™ Flu A-B/RSV/SARS-CoV-2 Vantage Test that ...
ELMWOOD PARK, N.J., Oct. 20, 2020 /PRNewswire/ -- BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), is now accepting specimens for a new multiplex COVID-19 and influenza test for ...
A single blood test called the TDB serochip helps in identifying the pathogen that is responsible for causing Lyme disease and seven other tick-borne pathogens. A single blood test called the ...
Aug. 15 (UPI) --The U.S. Food and Drug Administration has issued an Emergency Use Authorization for the first multiplex test for the Zika virus and three other viruses. The FDA made the authorization ...
The INSTI® Multiplex HIV-1/2 Syphilis Antibody Test delivers highly accurate results in just 60 seconds with a single sample—the fastest dual HIV/syphilis rapid test available. Now included in the ...
SALT LAKE CITY--(BUSINESS WIRE)--Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today ...
SALT LAKE CITY, Oct. 6, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular ...
Examination of patients’ responses to direct-to-consumer genetic susceptibility tests is needed to inform clinical practice. This study examined patients’ recall and interpretation of, and responses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback